HELP

Helus Pharma Inc. HELP

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$197.69M total
VR Adviser, LLC
$25.46M0.0%
ORBIMED ADVISORS LLC
$21.62M-14.6%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$20.23M+337.1%
MILLENNIUM MANAGEMENT LLC
$17.40M+9.0%
Rosalind Advisors, Inc.
$12.93M+27.7%
SPHERA FUNDS MANAGEMENT LTD.
$10.71M+64.2%
ACORN CAPITAL ADVISORS, LLC
$10.18M0.0%
DCF Advisers, LLC
$9.49M+107.4%
Sio Capital Management, LLC
$8.59MNew
Nan Fung Group Holdings Ltd
$6.53M+114.6%
Boxer Capital Management, LLC
$5.22M+23.4%
Logos Global Management LP
$4.96MNew
CITADEL ADVISORS LLC
$4.10M-29.2%
DAFNA Capital Management LLC
$3.40M+3.2%
Walleye Capital LLC
$3.32MNew
MORGAN STANLEY
$3.05M-55.0%
Knott David M Jr
$2.45M+5.7%
BANK OF AMERICA CORP /DE/
$2.23MNew
AdvisorShares Investments LLC
$1.93M+49.6%
JANE STREET GROUP, LLC
$1.86M+164.1%
JPMORGAN CHASE & CO
$1.64MNew
ROYCE & ASSOCIATES LP
$1.53M+49.7%
UBS Group AG
$1.45M-8.2%
SUPERSTRING CAPITAL MANAGEMENT LP
$1.35MNew
DIADEMA PARTNERS LP
$1.32MNew
See all 100 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

Loading ratio trend…

HELP key financials by period

Reported revenue, net income and operating margin by fiscal year, from Helus Pharma Inc.'s annual filings on SEC EDGAR.

Helus Pharma Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2021$864.0K$-32.2M—
Source: HELP filings on SEC EDGAR →

HELP insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Helus Pharma Inc. (HELP): stock profile, AI score and financials

Helus Pharma Inc. (HELP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. HELP is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of HELP by reported 13-F value include VR Adviser, ORBIMED ADVISORS, ADAGE CAPITAL PARTNERS GP, L.L.C., based on the most recent SEC filings. HELP trades on the Nasdaq exchange and files with the SEC under CIK 1833141. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HELP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Helus Pharma Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1833141 →